Computerized Personal Interventions for Alzheimer's Patients
NCT ID: NCT01329484
Last Updated: 2011-04-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
159 participants
INTERVENTIONAL
2011-03-31
2012-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive-motor Intervention Using Virtual Reality for Middle-aged Individuals at High Dementia Risk
NCT02832921
Effects of Transcranial Magnetic Stimulation (TMS) and Cognitive Training for Alzheimer Patients
NCT00909285
Tracking Technologies for the Analysis of Mobility in Alzheimer's Disease
NCT00743418
A Rehabilitation Intervention for Amnestic Mild Cognitive Impairment
NCT01283269
Efficacy of MindAhead's Digital Behavioral Activation Therapy in Adults with MCI or Mild Dementia
NCT06149013
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Increasingly, computerized systems are being designed to support both the cognitive assessment of patients with Alzheimer's disease and the administration of novel non-pharmacological interventions. Studies suggest that such systems may be of clear benefit. For example, in an initial study involving patients with AD, computerized cognitive training systems have been shown to be of value in providing a more standardized approach to cognitive training. Also, another study found that the use of a computerized system for reminiscence therapy was successful in facilitating patient-caregiver interaction.
Our research is a collaborative effort designed to test the effects of two such computer-supported interventions in patients with mild AD. The purpose of the research is to compare the efficacy of personalized computerized reminiscence therapy and that of computerized cognitive training to a control group. The reminiscence therapy program is based on developing an internet-based personalized reminiscence system, which will facilitate flexible interactive use by patients and caregivers. The importance of a personalized system is especially salient in immigrant, or in highly mobile, societies due to the heterogeneous background of the patients.
Separate preliminary studies have found positive effects of each system. The research will use various measures to evaluate the efficacy of both treatments, including the Mindstreams (NeuroTrax Corp., NJ) computerized neuropsychological assessment instrument, which will serve as the cognitive outcome measure.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cognitive training
Cognitive training
Cognitive training using a computerized system
Reminiscence therapy
Reminiscence therapy
Personalized reminiscence therapy using a computerized system
Control
This group will receive neither of the above interventions or any other similar interventions
No treatment
Participants in the control group will receive neither of the 2 experimental interventions or any other similar interventions.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Reminiscence therapy
Personalized reminiscence therapy using a computerized system
Cognitive training
Cognitive training using a computerized system
No treatment
Participants in the control group will receive neither of the 2 experimental interventions or any other similar interventions.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* MMSE score of 14-26
Exclusion Criteria
* Auditory impairment
* Psychiatric disorders
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shaare Zedek Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mental Health Center, Beer-Sheva
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tzvi Dwolatzky, MD
Role: PRINCIPAL_INVESTIGATOR
Mental Health Center, Beer-Sheva
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mental Health Center
Beersheba, , Israel
Memory Clinic, Shaare Zedek Medical Center
Jerusalem, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CPI-AD-TD-CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.